Physician profile
Bryce Einhorn
NPI 1891140158
$4,588.25
in general payments reported to CMS, 2019-2025
26 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $714 · 2021: $1,017 · 2022: $1,294 · 2023: $837 · 2024: $161 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Travel and Lodging: $360 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.48 |
| Travel and Lodging | $360.11 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $898.69 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $517.33 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $486.21 | 2020-2022 | |
| Abbott Laboratories | $481.36 | 2020-2025 | Amplatzer, Ultreon, Pressurewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $272.19 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $246.08 | 2019-2025 | |
| Chiesi USA, INC. | $219.96 | 2019-2022 | |
| Medtronic, INC. | $214.38 | 2022-2025 | Corevalve Evolut R, Onyx Frontier |
| Astellas Pharma US INC | $198.00 | 2020 | |
| Amgen INC. | $194.76 | 2020-2022 | |
| Abiomed | $160.85 | 2024-2025 | Impella |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Lantheus Medical Imaging, INC. | $81.33 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.76 | 2020-2022 | |
| Pfizer INC. | $66.32 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $64.59 | 2021-2024 | Watchman Flx |
| Acacia Pharma INC | $39.10 | 2021-2022 | |
| Novo Nordisk INC | $38.38 | 2021-2022 | |
| Esperion Therapeutics, INC. | $29.18 | 2021-2022 | |
| Teleflex LLC | $26.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $25.13 | 2022 | |
| Daiichi Sankyo INC. | $24.00 | 2022 | |
| Medtronic Vascular, INC. | $22.06 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $17.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.46 | 2022 | |
| Amarin Pharma, INC. | $17.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Einhorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.